He discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD.
He discusses his research in virology and how his team is working to produce better vaccines through understanding the immunology of helper T cells, germinal centers, and the human-naïve B-cell...
He discusses his research in virology and how his team is working to produce better vaccines through understanding the immunology of helper T cells, germinal centers, and the human-naïve B-cell...
In this podcast, Infectious Diseases Consultant Advisory Board Member Daniel Eiras, MD, discusses his experience with treating patients in New York City amid the COVID-19 pandemic, and how the pandemic has...
In this podcast, Infectious Diseases Consultant Advisory Board Member Daniel Eiras, MD, discusses his experience with treating patients in New York City amid the COVID-19 pandemic, and how the pandemic has...
In this podcast, Bill Kapogiannis, MD, discusses the multi-Federal agency SMILE Collaborative (Strategic Multisite Initiative for the Identification, Linkage and Engagement in Care of HIV-infected youth),...
In this podcast, Linda Beer, PhD, from the Centers for Disease Control and Prevention, talks about her team's latest analysis of US surveillance data of adults with HIV infection that examined the...
